| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silo Pharma, Inc. | Director | Options (right to buy) | 50K | May 23, 2025 | Direct | ||
| Hoth Therapeutics, Inc. | Director | Options | 25K | Aug 19, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SILO | Silo Pharma, Inc. | May 23, 2025 | 1 | $0 | 4 | May 27, 2025 | Director |
| HOTH | Hoth Therapeutics, Inc. | Aug 19, 2024 | 1 | $0 | 4 | Aug 21, 2024 | Director |
| HOTH | Hoth Therapeutics, Inc. | Jan 5, 2024 | 1 | $0 | 4 | Jan 8, 2024 | Director |
| HOTH | Hoth Therapeutics, Inc. | Jul 17, 2023 | 1 | $0 | 4 | Jul 18, 2023 | Director |
| HOTH | Hoth Therapeutics, Inc. | Dec 13, 2022 | 1 | $0 | 4 | Dec 13, 2022 | Director |
| HOTH | Hoth Therapeutics, Inc. | Dec 7, 2022 | 0 | $0 | 3 | Dec 13, 2022 | Director |
| SILO | Silo Pharma, Inc. | Sep 27, 2022 | 0 | $0 | 3 | Oct 4, 2022 | Director |